Skip to main content
. 2009 Nov 24;298(2):E296–E303. doi: 10.1152/ajpendo.00426.2009

Table 1.

Sequences and binding affinities of KP-10 and analogs

Peptide Sequence IC50, nM
KP-10 YNWNSFGLRF-NH2 1.0 + 0.3
Alanine screened analogs
ANA1 ANWNSFGLRF-NH2 23.2 + 14.3
ANA2 YAWNSFGLRF-NH2 145.1 + 138.0
ANA3 YNANSFGLRF-NH2 2.7 + 0.7
ANA4 YNWASFGLRF-NH2 43.5 + 15.5
ANA5 YNWNAFGLRF-NH2 0.8 + 0.4
ANA6 YNWNSAGLRF-NH2 109.5 + 89.8
ANA7 YNWNSFALRF-NH2 4.6 + 1.5
ANA8 YNWNSFGARF-NH2 77.4 + 10.0
ANA9 YNWNSFGLAF-NH2 42.3 + 6.7
ANA10 YNWNSFGLRA-NH2
Amino acid exchange analogs
ANA11 FNWNSFGLRF-NH2 3.5 + 2.1
ANA12 YDWNSFGLRF-NH2 29.1 + 13.5
ANA13 YNWDSFGLRF-NH2 140.2 + 60.6
ANA14 YNWNTFGLRF-NH2 2.3 + 1.6
ANA15 YNWNSYGLRF-NH2 87.5 + 30.7
ANA16 YNWNSFGIRF-NH2 39.9 + 8.1
ANA17 YNWNSFGLKF-NH2 9.8 + 2.6
ANA18 YNWNSFGLRH-NH2 378.4 + 266.0
Enantiomer exchange analogs
ANA19 ([dY]1KP-10) [dY]NWNSFGLRF-NH2 3.6 + 0.3
ANA20 YNWNS[dF]GLRF-NH2 252.9 + 144.0
ANA21 YNWNSFGLR[dF]-NH2 447.2 + 173.0

IC50 in nM are means ± SE (n = 3–5). KP, kisspeptin; ANA, analog. Binding assays were carried out against [125I]KP-54 binding to KISS1R in CHO-KISS1R membrane preparations. Each receptor binding assay was carried out in triplicate. Changes to the sequence of KP-10 are indicated in bold.